Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

10.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
Overview of DNA Repair02:25

Overview of DNA Repair

34.0K
In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
34.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.

EClinicalMedicine·2026
Same author

Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

Cancer discovery·2026
Same author

Interaction of Intraprocedural Antiplatelets and Intravenous Thrombolysis in Acute Intracranial Stenting: RESISTANT Registry Subanalysis.

Annals of clinical and translational neurology·2026
Same author

Comparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysis.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Advancing the applications of liquid biopsies in oncology.

Nature reviews. Genetics·2026
Same author

Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial.

Nature communications·2026

Related Experiment Video

Updated: Feb 18, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.8K

Targeting DNA damage in SCLC.

Victoria Foy1, Maximilian W Schenk1, Katie Baker2

  • 1Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, UK.

Lung Cancer (Amsterdam, Netherlands)
|November 28, 2017
PubMed
Summary
This summary is machine-generated.

Small cell lung cancer (SCLC) remains deadly due to early spread and chemo-resistance. Targeting DNA damage repair pathways offers a promising strategy to improve treatment efficacy for SCLC patients.

Keywords:
Checkpoint InhibitorsDNA Repair PathwaysLung CancerPARP InhibitorsSmall Cell Lung Cancer

More Related Videos

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response
05:01

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response

Published on: June 14, 2024

2.3K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

442

Related Experiment Videos

Last Updated: Feb 18, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.8K
Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response
05:01

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response

Published on: June 14, 2024

2.3K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

442

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Small cell lung cancer (SCLC) comprises 15% of global lung cancer cases.
  • Characterized by early dissemination and chemo-resistance, SCLC has a poor 5-year survival rate (<5%).
  • The standard first-line treatment (platinum and etoposide) has remained unchanged since the 1970s.

Purpose of the Study:

  • To review the rationale for targeting DNA damage response (DDR) in SCLC.
  • To summarize progress in evaluating novel DDR inhibitors for SCLC.
  • To highlight challenges in the clinical development of DDR inhibitors for SCLC.

Main Methods:

  • Literature review of studies on DNA damage, repair pathways, and cell cycle checkpoints in SCLC.
  • Analysis of current and emerging therapeutic strategies targeting DDR mechanisms.
  • Examination of clinical trial data and challenges for DDR inhibitors in SCLC.

Main Results:

  • SCLC cells' reliance on DNA damage repair pathways and checkpoints for survival in a high-damage environment.
  • Cytotoxic drugs and radiotherapy induce DNA damage, with cellular response determining treatment efficacy.
  • Recent advancements offer new strategies to exploit DDR mechanisms for improved therapeutic outcomes.

Conclusions:

  • Targeting DNA damage response pathways is a rational approach to enhance SCLC treatment.
  • Several novel DDR inhibitors are under evaluation, showing potential for clinical development.
  • Overcoming challenges in clinical development is crucial for realizing the full potential of DDR inhibitors in SCLC.